2017 Annual Meeting of the American Association for the Study of Liver Diseases*

October 20-24, 2017; Washington, DC
Review Capsule Summaries, download slides, and read ClinicalThought commentaries on key studies from Washington, DC 2017.

Hepatitis B

Capsules

Antiviral hepatitis B therapy associated with less necroinflammation in these patients with ALT ≤ 80 IU/L.

Released: October 24, 2017

Among patients with virologic breakthrough, 64% had evidence of nonadherence or residual low levels of viremia.

Released: October 25, 2017

Interim analysis detects no significant difference in response between patients switched to pegIFN plus entecavir alone or with added GM-CSF.

Released: October 25, 2017
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Educational grant provided by:
AbbVie
Gilead Sciences
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?